Clinical Trial Update: Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial PALISADE-4 evaluating fasedienol nasal spray for acute treatment of anxiety in adults with Social Anxiety Disorder; recruitment is ongoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• Fasedienol nasal spray (fasedienol)

Snippet

Sponsor: VistaGen Therapeutics, Inc. | Conditions: Social Anxiety Disorder (SAD) | Phase 3 | Status: RECRUITING